Voloridge Investment Management
HRMY icon

Voloridge Investment Management’s Harmony Biosciences HRMY Stock Holding History

Voloridge Investment Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-309,404
Closed -$10.3M – 1257
2025
Q1 		$10.3M Sell
309,404
-46,668
-13% -$1.67M 0.04% 563
2024
Q4 		$12.3M Buy
356,072
+69,886
+24% +$2.4M 0.04% 517
2024
Q3 		$11.4M Sell
286,186
-49,239
-15% -$1.73M 0.04% 544
2024
Q2 		$10.1M Sell
335,425
-10,801
-3% -$325K 0.04% 554
2024
Q1 		$11.6M Sell
346,226
-65,578
-16% -$2.1M 0.04% 452
2023
Q4 		$13.3M Buy
411,804
+142,637
+53% +$3.98M 0.05% 409
2023
Q3 		$8.82M Buy
269,167
+19,045
+8% +$661K 0.04% 489
2023
Q2 		$8.8M Buy
250,122
+146,937
+142% +$5.07M 0.04% 499
2023
Q1 		$3.37M Buy
103,185
+98,999
+2,365% +$4.51M 0.02% 803
2022
Q4 		$231K Sell
4,186
-19,214
-82% -$1.06M ﹤0.01% 1369
2022
Q3 		$1.04M Sell
23,400
-36,113
-61% -$1.76M 0.01% 1154
2022
Q2 		$2.9M Sell
59,513
-133,460
-69% -$6.01M 0.02% 890
2022
Q1 		$9.39M Buy
192,973
+139,433
+260% +$5.69M 0.05% 428
2021
Q4 		$2.28M Buy
+53,540
New +$2.13M 0.01% 1025

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management's HRMY Position: Q2 2025 in Review

Voloridge Investment Management sold out of Harmony Biosciences (HRMY) in Q2 2025, closing a stake of 309,404 shares — an estimated $10.3M sold.

Voloridge Investment Management first reported a position in HRMY in Q4 2021 and held it in 14 quarters. The position peaked at $13.3M in Q4 2023. 279 funds tracked by Wall St. Rank hold HRMY as of Q2 2025.

  • Voloridge Investment Management reported no remaining Harmony Biosciences position as of Q2 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 309,404 Harmony Biosciences shares in Q2 2025, an estimated $10.3M.
  • Voloridge Investment Management first reported a position in Harmony Biosciences in Q4 2021 and held it in 14 quarters.
  • Voloridge Investment Management's Harmony Biosciences position peaked at $13.3M in Q4 2023.
  • 279 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2025.

Based on Voloridge Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.